-
Crisaborole
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Crisaborole Atopic Dermatitis Thiab Eczema Pfizer -
Etelcacetide
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Etelcacetide Secondary hyperparathyroidism (HPT) Amgen -
Abemaciclib
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Abemaciclib Mob cancer mis, kho mob qog noj ntshav prostate Eli Lily Kaum Ib Hlis 15, 2029 -
Deucracitinib
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Deucracitinib Anti plaque psoriasis Bristol-Myers Squibb Company Nov 07, 2033 -
Apremilast
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Apremilast psoriatic mob caj dab Celgene -
Remdesivir
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Remdesivir Antiviruls (Ebola, Covid-19) Kile-a -
Paxlovid
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Paxlovid Covid 19 Pfizer -
Pomalidomide
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Pomalidomide Oncology tshuaj Celgene -
Nirmatrelvir
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Nirmatrelvir 3C-Like Protease (3CLPRO) Inhibitor Thiab SARS-Cov-2 Mpro Inhibitor -
Eltrombopag
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Eltrombopag ITP & Aplastic anemia Novartis & GSK Tsib. Peb Hlis 20, 2023 -
Ruxolitinib
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Ruxolitinib Myelofibrosis Novartis Lub Xya Hli 6, 2024 -
Crisaborole
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Crisaborole Atopic Dermatitis thiab Eczema Pfizer Lub Rau Hli 11, 2026